Learn More
Invitrogen™ USH1C Recombinant Rabbit Monoclonal Antibody (006)

Description
This product is preservative free. It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%). Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire. This antibody has specificity for Human USH1C/Harmonin.
Specifications
Specifications
| Antigen | USH1C |
| Applications | ELISA |
| Classification | Recombinant Monoclonal |
| Clone | 006 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative |
| Gene | USH1C |
| Gene Accession No. | Q9Y6N9 |
| Gene Alias | 2010016F01Rik; AIE75; AIE-75; Antigen NY-CO-38/NY-CO-37; autoimmune enteropathy-related antigen AIE-75; DFNB18; DFNB18A; harmonin; harmonin a1; harmonin pseudogene; hypothetical protein LOC530709; hypothetical protein LOC564412; NY-CO-37; NY-CO-38; PDZ domain-containing protein; PDZ-45; PDZ73; PDZ-73; PDZ-73 protein; PDZ-73/NY-CO-38; PDZD7C; Protein PDZ-73; Renal carcinoma antigen NY-REN-3; USH1 protein network component harmonin; Ush1c; ush1cpst; Usher syndrome 1C; Usher syndrome 1C (autosomal recessive, severe); Usher syndrome 1C homolog; usher syndrome type-1C protein; Usher syndrome type-1C protein homolog; zgc:136806 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.